China’s biggest pharma firm invites PH to join COVID-19 vaccine trial

China’s biggest pharma firm invites PH to join COVID-19 vaccine trial

Original article courtesy of

By: Katrina Hallare

MANILA, Philippines — China’s biggest pharmaceutical company, the state-owned Sinopharm, has invited the Philippines to join its trial of a vaccine for the coronavirus disease (COVID-19), Health Secretary Francisco Duque III bared Wednesday at the Senate Committee of the Whole hearing.

“We have a letter from China, from Sinopharm, China’s biggest pharmaceutical company, which offered to include us in its global clinical trial for their newly-developed vaccine,” Duque said.

Previously, Sinopharm also extended a similar invitation to Pakistan.

In the Senate hearing, Duque also revealed that 148 patients had agreed to be part of the World Health Organization’s (WHO) Solidarity Trial for COVID-19 treatment.

As of Wednesday, the Philippines has 13,221 COVID-19 cases, of whom 842 have died while 2,932 have recovered.

China-Philippines Unified Enterprises Inc.

Our Philippine-based consultancy firm can bring your investments to a new horizon. We are dedicated to providing services and concrete solutions for your investment needs. China Philippines Unified Enterprises promises to deliver efficient service, genuine trust, and unparalleled professionalism.


Office Address:

30/F Ore Central Tower
31st Street corner 9th Avenue
Bonifacio Global City
Taguig City 1634

Telephone: (+632) 7220 0688

Mobile: (+63) 917 110 7653

Email: [email protected]


For employment opportunities, please send an application letter together with your curriculum vitae to: [email protected]
Close Menu